3-(3-(4-(Aminomethyl)phenyl)-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine Hydrochloride

ID: ALA4517839

PubChem CID: 60155179

Max Phase: Preclinical

Molecular Formula: C18H17ClN6

Molecular Weight: 316.37

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cl.NCc1ccc(-n2c(-c3cccnc3N)nc3cccnc32)cc1

Standard InChI:  InChI=1S/C18H16N6.ClH/c19-11-12-5-7-13(8-6-12)24-17(14-3-1-9-21-16(14)20)23-15-4-2-10-22-18(15)24;/h1-10H,11,19H2,(H2,20,21);1H

Standard InChI Key:  KCMOQQVRPVPIKB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    7.8670  -21.0375    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.7268  -17.8379    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1936  -17.1568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6874  -16.5011    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9341  -17.6062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9118  -16.7831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1889  -16.3926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4878  -16.8242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5143  -17.6504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2376  -18.0371    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0169  -17.1341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4493  -17.8390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2740  -17.8159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6673  -17.0888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2297  -16.3833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4065  -16.4099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0051  -18.6133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4685  -19.2426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7455  -20.0196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5585  -20.1688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0941  -19.5346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8143  -18.7599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9715  -15.7080    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8371  -20.9462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6496  -21.0936    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  5  2  1  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  3 11  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  2 17  1  0
 16 23  1  0
 20 24  1  0
 24 25  1  0
M  END

Associated Targets(Human)

AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT2 Tchem Serine/threonine-protein kinase AKT2 (4301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT3 Tchem Serine/threonine-protein kinase AKT3 (3157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 316.37Molecular Weight (Monoisotopic): 316.1436AlogP: 2.52#Rotatable Bonds: 3
Polar Surface Area: 95.64Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.34CX LogP: 1.99CX LogD: 0.07
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.61Np Likeness Score: -0.99

References

1. Lapierre JM, Eathiraj S, Vensel D, Liu Y, Bull CO, Cornell-Kennon S, Iimura S, Kelleher EW, Kizer DE, Koerner S, Makhija S, Matsuda A, Moussa M, Namdev N, Savage RE, Szwaya J, Volckova E, Westlund N, Wu H, Schwartz B..  (2016)  Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor.,  59  (13): [PMID:27305487] [10.1021/acs.jmedchem.6b00619]

Source